Anchor Procedures in IO

Sunday, March 5, 2023

3:00 PM – 4:30 PM

Location:Phoenix Convention Center, 228AB

CE: 1.5 Credits

Coordinator(s)

Beau Toskich, MD, FSIR

Professor
Department of Radiology, Division of Interventional Radiology, Mayo Clinic, Jacksonville, FL 32224, United States

Disclosure(s): No relevant disclosure to display
Lindsay Thornton, MD

Assistant Professor of Clinical Interventional Radiology
University of Miami Miller School of Medicine

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Beau B. Toskich, MD, FSIR: No relevant disclosure to display

Lindsay Thornton, MD: No financial relationships to disclose

The purpose of this session is to highlight the key IO procedures for the most common disease processes in our field by providing an evidence-based, concise framework. The content presented is intended to prepare any new interventional oncologist for tumor board discussions and practice building. All talks during this session will include landmark/key articles, current guidelines, and best practice on the respective topics.

Learning Objectives:

Identify the landmark articles and/or best data for the major disease processes and procedures performed in interventional oncology.
Describe current practice guidelines for the the major disease processes and procedures performed in interventional oncology.
Recommend best practice taking into account everyday clincal nuances as it pertains to the major disease processes and procedures performed in interventional oncology.

Presentations:

3:00 PM – 3:06 PM

Ablation for HCC
Speaker: Kirema Garcia-Reyes, MD (she/her/hers) – Icahn School of Medicine at Mount Sinai
3:06 PM – 3:12 PM

TACE for HCC
Speaker: Charles Martin, III, MD, MBA, FSIR (he/him/his) – Cleveland Clinic
3:12 PM – 3:18 PM

Radioembolization for HCC
Speaker: Guy Johnson, MD, PharmD – University of Washington Medicine
3:18 PM – 3:24 PM

Ablation for Colorectal Cancer
Speaker: Amanda R. Smolock, MD, PhD – Medical College of Wisconsin
3:24 PM – 3:30 PM

Intra-arterial Therapies for Colorectal Cancer
Speaker: Evans Heithaus, MD – University of Florida
3:30 PM – 3:36 PM

IO for Renal Cell Carcinoma
Speaker: Andrew Gunn, MD – University of Alabama At Birmingham
3:36 PM – 3:42 PM

Lung Ablation
Speaker: Damian E. Dupuy, MD, FACR (he/him/his) – Cape Cod Hospital
3:42 PM – 3:48 PM

Role of IO for Neuroendocrine Cancer
Speaker: Ghassan El-Haddad, MD – Moffitt Cancer Center and Research Institute
3:52 PM – 3:58 PM

Role of IO for Cholangiocarcinoma
Speaker: Bela Kis, MD, PhD – Moffitt Cancer Center
3:58 PM – 4:04 PM

Role of IO for Melanoma
Speaker: Rahul Sheth, MD – MD Anderson
4:10 PM – 4:16 PM

Role of IO for Malignant Bone Lesions
Speaker: David Prologo, MD – Emory University
4:16 PM – 4:30 PM

Q & A
Coordinator: Beau B. Toskich, MD, FSIR – Department of Radiology, Division of Interventional Radiology, Mayo Clinic, Jacksonville, FL 32224, United States